(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMAWRITE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PHARMAWRITE

ST13

US500000078844772

Class

41, 42

Filing

78844772

Registration

3201888

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

01/24/2026

Classification

Registered

Trademark type

Word

Nice classes

41, 42

Filing date

03/23/2006

Registration date

01/23/2007

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/27/2016

Last transaction

01/24/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/09/2004

First use in commerce

04/09/2004

Drawing code

4

Owner type

16

Owner location

PRINCETON, NJ

Examiner

CASE, LEIGH CAROLINE

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MEDVAL SCIENTIFIC INFORMATION SERVICES, LLC
RJL-LPG, LLC
PharmaWrite, LLC

Representatives

Jessica R. Friedman Jobson Healthcare Information LLC

Technical classification

Nice Classes

Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Medical communication servicespublishing journal articlesmonographspamphlets and scientific reports; organizing and conducting educational conferencescourses and seminars; convening advisory boards; and developing and disseminating educational materials for othersall in the pharmaceutical field

Class 42

Medical communication servicescustom and technical writingeditingeditorial consultation in the pharmaceutical field

Publications

History of USPTO decisions and trademark events.

25 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/23/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/29/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/14/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/30/2021

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/27/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/27/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/27/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/27/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

04/07/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/23/2016

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/30/2014

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/24/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/24/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/24/2012

E815

TEAS SECTION 8 & 15 RECEIVED

10/08/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/16/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

01/23/2007

PUBO

PUBLISHED FOR OPPOSITION

11/07/2006

NPUB

NOTICE OF PUBLICATION

10/18/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/20/2006

ALIE

ASSIGNED TO LIE

09/15/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2006

DOCK

ASSIGNED TO EXAMINER

09/07/2006

MPMK

NOTICE OF PSEUDO MARK MAILED

04/11/2006

NWAP

NEW APPLICATION ENTERED

03/29/2006

Continuous trademark protection

Get notified about every new filing that threatens PHARMAWRITE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.